American Gene Technologies (AGT) Moves HQ to New Facility, Expands Lab Space for HIV and Cancer Cure Research

NEXT STORY
Orion’s phase 3 REFALS trial evaluating the efficacy of oral levosimendan in treatment of ALS patients did not reach its pre-specified endpoints
PREV STORY
Basilea announces completion of its transaction involving a partial repurchase of its existing bond and the issuance of a new bond
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aptevo Therapeutics Announces New IXINITY Supply Available May 2017

SEATTLE, March 15, 2017 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq:APVO), a biotechnology company ...

author_avatar
NASDAQ Market News

China Medical Device Sourcing Market Report 2015 – Cardiovascular, Orthopedic, General Hospital & Radiology Devices

Dublin, Dec. 11, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/xf86j4/medical_device) has announced the ...

author_avatar
NASDAQ Market News

FIT Biotech Oy: Conversion of FIT Biotech Oy’s Convertible Capital Notes into shares

FIT Biotech Oy Company release February 19, 2018 at 2:00 PM EET Conversion of ...

author_avatar
NASDAQ Market News